BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200219T150000
DTEND;TZID=America/New_York:20200219T160000
DTSTAMP:20200208T165510Z
CREATED:20200208T165105Z
LAST-MODIFIED:20200208T165510Z
UID:39162-1582124400-1582128000@globalbiodefense.com
SUMMARY:Public Health Emergency Preparedness (PHEP) Monthly Call
DESCRIPTION:PHEP Recipient Monthly Conference Call Scheduled for February 19 \nCDC’s next monthly conference call with PHEP recipients will be held from 3 p.m. to 4 p.m. EDT on Wednesday\, February 19. Participant information is provided below. \n  \nConference Call Information \nBridge Line: (888) 566-1873 \nParticipant Code: 3358383 \n  \nThe Public Health Emergency Preparedness (PHEP) cooperative agreement is a critical source of funding for state\, local\, and territorial public health departments. Since 2002\, the PHEP cooperative agreement has provided assistance to public health departments across the nation. This helps health departments build and strengthen their abilities to effectively respond to a range of public health threats\, including infectious diseases\, natural disasters\, and biological\, chemical\, nuclear\, and radiological events. Preparedness activities funded by the PHEP cooperative agreement specifically targeted the development of emergency-ready public health departments that are flexible and adaptable.
URL:https://globalbiodefense.com/event/public-health-emergency-preparedness-phep-monthly-call/
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200224T140000
DTEND;TZID=America/New_York:20200224T150000
DTSTAMP:20200126T214159Z
CREATED:20200126T193833Z
LAST-MODIFIED:20200126T214159Z
UID:37781-1582552800-1582556400@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \nh/t NACCHO for originally posting this information.
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness-4/
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200226
DTEND;VALUE=DATE:20200227
DTSTAMP:20200206T192309Z
CREATED:20200206T191959Z
LAST-MODIFIED:20200206T192309Z
UID:38920-1582675200-1582761599@globalbiodefense.com
SUMMARY:Emerging Bioethical Issues in Biomedical Research: A Workshop
DESCRIPTION:A planning committee of the National Academies of Sciences\, Engineering\, and Medicine will conduct a one day workshop on Feb 26\, 2020 to bring together stakeholders to discuss potential ethical issues that may arise from new and emerging trends in biomedical research (including behavioral and social research) and society. \nThe workshop will identify a range of current and emerging bioethical issues – both in basic and clinical research – and explore a broad-range of stakeholder perspectives. Input will be sought from a variety of perspectives which may include patients/participants/individuals\, bioethicists\, academic and industry researchers\, clinicians\, and government representatives. The workshop will describe the state of the emerging science and potential pressing\, recurring\, emerging\, and/or anticipated future bioethical issues in biomedical research and society that fall within the scope of the research and policy activities of the NIH. Potential topics may include: \n\nUse of digital technologies\, artificial intelligence\, and machine learning in biomedical research and clinical care;\nEmerging ethical challenges for sharing data from human research participants and use of human biospecimens;\nHealth equity and health disparities in research\, including:\n\nRecognizing and addressing barriers to participation in research and clinical care across diverse populations and groups\nUnderstanding the impact of cultural and social context on health and disease\nEquitable distribution of the benefits and burdens of research;\n\n\nInnovative study designs\, including crowdsourcing of research and citizen science;\nNovel approaches for enhancing bioethics infrastructure and training;\nNew means for assessing and enhancing scientific workforce diversity; and/or\nInnovative solutions for enhancing research oversight infrastructure.\n\nGiven the broad scope of bioethical issues in research and the difficulty in addressing all possible issues in a single workshop\, the following topics fall outside the scope of this workshop as they are being addressed in multiple other venues: gene editing\, gene drives\, human-animal chimera research\, human fetal tissue research\, neuroethics\, and animal care and welfare. The planning committee will develop the agenda for the workshop\, select and invite speakers and discussants\, and moderate or identify moderators for the discussions. A workshop proceedings will be prepared by a designated rapporteur based on the information gathered and discussions held during the workshop in accordance with National Academies institutional policies and procedures. \nNote: Registration for in-person attendance is full. You may register for the webcast HERE. If you are interested in signing up for the in-person waitlist\, please register HERE and we will contact you if a spot becomes available.
URL:https://globalbiodefense.com/event/emerging-bioethical-issues-in-biomedical-research-a-workshop/
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200302T113000
DTEND;TZID=America/New_York:20200302T120000
DTSTAMP:20200301T230419Z
CREATED:20200301T230209Z
LAST-MODIFIED:20200301T230419Z
UID:40566-1583148600-1583150400@globalbiodefense.com
SUMMARY:COVID-19 Live Webcast with Johns Hopkins Experts
DESCRIPTION:With COVID-19 now spreading via community transmission in the U.S. and the World Health Organization raising its risk assessment to “very high\,” the Johns Hopkins Bloomberg School of Public Health will host a 30-minute webcast featuring some of the best minds addressing this global health concern. \nYou’ll hear from Dr. Jennifer Nuzzo and Dr. Tara Kirk Sell of the Johns Hopkins Center for Health Security and Lauren Sauer of the Johns Hopkins Office of Critical Event Preparedness and Response. The conversation will be moderated by Dr. Joshua Sharfstein\, Vice Dean of the Johns Hopkins Bloomberg School of Public Health and former secretary of Maryland’s Department of Health. \nThey’ll discuss the findings of the Global Health Security Index referenced by President Trump last week\, what you need to know about community transmission and how to protect yourself from misinformation. They will also answer viewer questions submitted before and during the broadcast. \nSpeakers\n\nJennifer Nuzzo\, DrPH\, SM\nSenior Scholar\, Johns Hopkins Center for Health Security\nJohns Hopkins Bloomberg School of Public Health\nTara Kirk Sell\, PhD\, MA\nSenior Scholar\, Johns Hopkins Center for Health Security\nJohns Hopkins Bloomberg School of Public Health\nLauren M. Sauer\, MS\nDirector of Operations\, Johns Hopkins Office of Critical Event Preparedness and Response\nJohns Hopkins University School of Medicine\nJosh Sharfstein\, MD\nModerator\nVice Dean for Public Health Practice and Community Engagement\nJohns Hopkins Bloomberg School of Public Health\n\nA recording will be made available via on The Hub’s dedicated coronavirus page at https://hub.jhu.edu/novel-coronavirus-information/ and across Bloomberg School channels. \nThe Johns Hopkins Bloomberg School of Public Health will host additional webcasts as the coronavirus outbreak continues. Follow us on Twitter\, Facebook\, LinkedIn\, and Instagram to be notified about future broadcasts. \nThe Bloomberg School is also launching a daily “Public Health On Call” podcast with an immediate focus on the coronavirus outbreak. Subscribe via YouTube or Libsyn.
URL:https://globalbiodefense.com/event/covid-19-live-webcast-with-johns-hopkins-experts/
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200302T140000
DTEND;TZID=America/New_York:20200302T150000
DTSTAMP:20200126T224530Z
CREATED:20200126T224350Z
LAST-MODIFIED:20200126T224530Z
UID:37784-1583157600-1583161200@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \nh/t NACCHO for originally posting this information.
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness-5/
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200310T133000
DTEND;TZID=America/New_York:20200310T143000
DTSTAMP:20240623T230635Z
CREATED:20200305T230620Z
LAST-MODIFIED:20240623T230635Z
UID:40918-1583847000-1583850600@globalbiodefense.com
SUMMARY:Journalists Covering COVID-19: What Do You Need to Know
DESCRIPTION:Association of Health Care Journalists (AHCJ) members are invited to a special webcast event “Covering COVID-19: What Do You Need to Know?” on 10 March 2020. \nThe COVID-19 outbreak story is evolving quickly and there are many unknowns about the epidemic\, including how contagious the virus is\, its mortality rate and whether there is undetected spread occurring outside of China. Providing accurate information to the public is more important than ever in this moment of uncertainty. Hear a panel of infectious disease experts and a journalist explain what is known\, what to watch out for\, where to find trusted resources and how to combat misinformation and confusion. \n\nMaryn McKenna\, independent journalist\, author; Senior Fellow of the Center for the Study of Human Health at Emory University\nMichael Osterholm\, Ph.D.\, M.P.A.\, director\, Center for Infectious Disease Research and Policy\nSaskia Popescu\, senior infection preventionist\, ELBI Fellow and managing editor; HonorHealth\, Johns Hopkins Center for Health Security\, Pandora Report\nAngie Rasmussen\, Ph.D.\, Columbia University Mailman School of Public Health\, Associate Research Scientist\nModerator: Bara Vaida\, AHCJ core topic leader/infectious diseases\n\nSaskia Popescu is an experienced infectious disease epidemiologist and infection preventionist with a strong background in project management\, translation of complex issues into frontline applications\, and enhancing healthcare biopreparedness. She is passionate about healthcare biopreparedness\, antimicrobial resistance\, and driving change across sectors in global health security. \nAngie Rasmussen\, Ph.D.\, is an associate research scientist at Columbia University’s Mailman School of Public Health. She is a virologist studying host responses to infection by combining classical virology with modern systems biology approaches. Her research objectives are to identify host response signatures predictive of infection severity or disease outcome and host pathways to target drug development or repurposing. She is particularly interested in viruses that are highly pathogenic\, newly emergent or likely to emerge because of climate change\, land development\, or ecological disruption. \nMaryn McKenna is a journalist and book author and teaches health and science writing and storytelling\, and media literacy. She has reported from epidemics and disasters\, and farms and food production sites\, on most of the world’s continents\, including a field hospital in New Orleans during Hurricane Katrina\, to Midwestern farms devastated by the 2015 epidemic of avian flu. She writes for The New York Times Magazine\, The New Republic\, WIRED\, Smithsonian\, The Atlantic\, NPR\, and numerous other magazines and sites. She is the author of the 2017 bestseller Big Chicken: The Incredible Story of How Antibiotics Created Modern Agriculture and Changed the Way the World Eats (National Geographic Books\, Sept. 2017)\, which received the 2018 Science in Society Award\, making her a two-time winner of that prize. \nPlease visit the AHCJ’s Covering COVID-19: What Do You Need to Know event website for more information.
URL:https://globalbiodefense.com/event/journalists-covering-covid-19-what-do-you-need-to-know/
CATEGORIES:Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200318T100000
DTEND;TZID=America/New_York:20200318T154500
DTSTAMP:20200210T161026Z
CREATED:20200210T160543Z
LAST-MODIFIED:20200210T161026Z
UID:39238-1584525600-1584546300@globalbiodefense.com
SUMMARY:Next Evolution: Overhauling Key Elements of Biodefense
DESCRIPTION:The Bipartisan Commission on Biodefense will convene a meeting entitled ‘Next Evolution: Overhauling Key Elements of Biodefense‘ on March 18\, 2020 in Washington D.C. and made available by webcast. \nThis meeting aims to inform the assessment of biodefense programs with structural challenges that impede the government’s ability to safeguard the Nation. \nTopics to be discussed at this meeting include the: \n\nSelect Agent Program\nBioWatch Program\nHospital Preparedness Program\n\nSpeakers will share their perspectives\, experiences\, challenges\, and recommended solutions with regard to federal biodetection\, pathogen security\, and hospital preparedness programs. \nRegistration is required and attendance is free. \nWednesday\, March 18\, 2020 \n10:00 AM – 3:45 PM \nHudson Institute \n1201 Pennsylvania Avenue\, NW\, 4th floor \nWashington\, DC 20004 \nSee map \n  \n 
URL:https://globalbiodefense.com/event/next-evolution-overhauling-key-elements-of-biodefense/
LOCATION:Hudson Institute\, 1201 Pennsylvania Avenue Northwest\, #400\, Washington\, DC\, 20004\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200324
DTEND;VALUE=DATE:20200325
DTSTAMP:20200323T203331Z
CREATED:20191211T055500Z
LAST-MODIFIED:20200323T203331Z
UID:35083-1585008000-1585094399@globalbiodefense.com
SUMMARY:The Role of Digital Health Technologies in Drug Development - Webcast
DESCRIPTION:The Role of Digital Health Technologies in Drug Development: A Workshop will be webcast on March 24\, 2020. \nAs digital health technologies (e.g. smartphone apps\, wearables\, and mobile-device-based tools) – hardware and software – become increasingly available to consumers\, providers\, and researchers\, there are new opportunities to address critical barriers or “pain points\,” better connect patients and health care providers\, and incorporate patient input throughout the drug research and development (R&D) life cycle. However\, a lack of clarity when it comes to the evaluation\, selection\, and implementation of digital health technologies has impeded the practical application of these innovations. Lessons learned from the direct-to-consumer genomics industry\, which has been increasingly moving into the clinical health space over the last 10 years\, may help inform the integration of digital health technologies into drug R&D. \nThis workshop will provide a venue to discuss challenges and opportunities in digital health technologies for improving the probability of success in drug development and enabling precision medicine. Workshop participants may consider key components for an evidence-based framework for applying digital health technologies towards drug research and development. \nThe Forum on Drug Discovery\, Development\, and Translation and the Roundtable on Genomics and Precision Health will host a public workshop on March 24\, 2020 which will feature invited presentations and discussions to: \nDiscuss challenges/questions that digital health technologies may be uniquely suited to address and opportunities for digital health technologies to enable better patient care and more efficient clinical trials; \nConsider strategies for evaluating and selecting digital health technologies that are fit-for-purpose in drug development (e.g. establishing appropriate evidentiary criteria); \nDiscuss privacy\, ethical\, and regulatory issues related to the use of digital health technologies; \nExamine currently validated and/or FDA-approved drug development applications for digital health technologies; \nConsider opportunities to enable the practical application of digital health technologies for improving drug development (e.g. sharing best practices for the validation and use of digital health technologies\, harmonizing guidelines across sectors).
URL:https://globalbiodefense.com/event/the-role-of-digital-health-technologies-in-drug-development-webcast/
LOCATION:Webinar
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200324
DTEND;VALUE=DATE:20200326
DTSTAMP:20200323T210103Z
CREATED:20200319T205750Z
LAST-MODIFIED:20200323T210103Z
UID:42054-1585008000-1585180799@globalbiodefense.com
SUMMARY:BIO Coronavirus Collaboration Initiative Virtual Summit
DESCRIPTION:The Biotechnology Innovation Organization (BIO) is hosting a virtual summit to help companies working on COVID-19 treatments\, diagnostics and vaccines to come together to discuss challenges and opportunities with government officials and other stakeholders. \nThe two-day summit will take place on Tuesday\, March 24 and Wednesday\, March 25\, and will be led by BIO President and CEO Jim Greenwood and Dr. George Scangos\, President and CEO of Vir Biotechnology. BIO Board Chairman Dr. Jeremy Levin\, CEO of Ovid Therapeutics\, appointed Dr. Scangos to oversee the BIO Coronavirus Collaboration Initiative\, which is intended to help connect innovators with partners across both the industry and inside the federal government to combat the coronavirus. \nThe summit will include leaders from biotech and pharmaceutical companies\, global academic experts in virology and immunology\, and non-governmental organizations. Those invited to participate include Ambassador Deborah Birx\, Dr. Robert Kadlec\, and other senior leaders from key government offices\, including the U.S. Department of Defense\, U.S. Department of Health & Human Services\, the Centers for Disease Control and Prevention\, National Institutes of Health\, and the Food and Drug Administration. Information regarding confirmed guests will be provided at a later date. \nAs an international trade association representing more than 700 biotechnology companies\, BIO is playing a unique role in organizing and coordinating the activities of many of its companies. More than 45 member companies are working to address coronavirus and more than 20 have products in various stages of development. \n“Close collaboration between America’s biopharmaceutical companies and the U.S. government is leading the global race to develop vaccines and cures to protect society from the coronavirus\,” said BIO President and CEO Jim Greenwood. “Our researchers and scientists are at the forefront of this important effort\, and they will answer the challenge just as they always have. This virtual summit is a critical step to helping industry leaders\, government officials\, and other vital partners collaborate and ultimately accelerate the development of new medicines to overcome this global threat. BIO is uniquely positioned to help drive this collaboration\, and this is one step in our broader efforts to combat the coronavirus.” \n“Across the biopharmaceutical industry\, men and women are working tirelessly under difficult circumstances to combat the coronavirus\,” said Dr. Scangos.“We are witnessing the true motivation of people in the industry – to do everything we can to bring medicines to people who need them. I am gratified to see people working incredibly hard to bring forward treatments for Covid-19 as quickly as humanly possible. I am pleased to help lead this virtual summit\, which will help facilitate the collaboration and public-private partnerships necessary to treat the sick and prevent further spread of the coronavirus.” \nThe virtual summit will feature presentations and discussions on the latest epidemiologic developments related to the coronavirus\, response work that is underway\, and where critical gaps exist in current R&D and response efforts. The meeting will focus on three key areas of the response: diagnosing the virus\, treating those with the virus\, and preventative measures to contain further transmission of the virus.
URL:https://globalbiodefense.com/event/bio-coronavirus-collaboration-initiative-virtual-summit/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200325T150000
DTEND;TZID=America/New_York:20200325T163000
DTSTAMP:20200325T061035Z
CREATED:20200324T060239Z
LAST-MODIFIED:20200325T061035Z
UID:42230-1585148400-1585153800@globalbiodefense.com
SUMMARY:Responding to COVID-19 Webinar: The Science of Social Distancing
DESCRIPTION:Brought to you by the American Public Health Association and the National Academy of Medicine\, The Science of Social Distancing webinar series will explore the state of the science surrounding the current outbreak of COVID-19 in the United States and globally\, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health\, infectious disease\, risk communication\, and crisis standards of care. \n\n\nBrought to you by the American Public Health Association and the National Academy of Medicine\, this webinar series will explore the state of the science surrounding the current outbreak of COVID-19 in the United States and globally\, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health\, infectious disease\, risk communication\, and crisis standards of care. \nThe webinar will feature a panel of expert speakers\, including: \n\nNancy Messonnier\, MD — Director\, National Center for Immunization and Respiratory Diseases\, Centers for Disease Control and Prevention\nMarc Lipsitch\, DPhil — Director\, Center for Communicable Disease Dynamics\, Harvard T. H. Chan School of Public Health\nMitch Stripling — National Director\, Emergency Preparedness and Response\, Planned Parenthood and former assistant commissioner of Agency Preparedness and Response for New York City\nHoward Markel\, MD\, PhD — George E. Wantz Distinguished Professor of the History of Medicine and Director of the Center for the History of Medicine\, University of Michigan\n\nThe webinar series will draw from and complement existing advisory activities underway at APHA and the National Academies\, including the Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats\, which was convened for the purpose of advising the White House and federal agencies on the U.S. response to COVID-19. \nThe series will rapidly and regularly provide trustworthy scientific analysis of the latest COVID-19 developments for the benefit of policymakers\, public health and health care officials\, and the general public. The series will explore the scientific basis for guidance issued by government\, health and public health organizations\, and industry\, as well as answer questions that are top of mind for its audiences.
URL:https://globalbiodefense.com/event/responding-to-covid-19-webinar-the-science-of-social-distancing/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200326
DTEND;VALUE=DATE:20200327
DTSTAMP:20200323T164958Z
CREATED:20200323T164525Z
LAST-MODIFIED:20200323T164958Z
UID:41944-1585180800-1585267199@globalbiodefense.com
SUMMARY:Policy vs. Pandemics: Polarization and Public Health Emergency Preparedness
DESCRIPTION:George Mason University Schar School of Policy and Government Biodefense\, MPP and MPA Programs will co-host a no-fee webinar event\, “Policy vs. Pandemics: Polarization and Public Health Emergency Preparedness” on March 26\, 2020 from 6:00pm – 7:30pm Eastern. \nThe sweeping effects of the on-going COVID-19 pandemic on the social\, economic\, and political framework of the United States highlights the vital importance of a resilient public health infrastructure. In the aftermath of this unprecedented pandemic\, the United States will need to reconsider its approach to biosurveillance\, public health emergency preparedness\, intergovernmental coordination\, and the development of countermeasures in advance of the next health crisis. In the past\, such efforts have been hindered by partisan polarization between Republicans and Democrats\, even as some crucial public health emergency policy was only made possible through bipartisan cooperation. While considering lessons from the past\, this discussion will address bipartisan efforts to move forward on approaches to protect the American people in the future\, such as the implementation of the National Biodefense Strategy. \nDr. Nathan Myers is an associate professor of political science and public administration at Indiana State University. His research interests include public health policy\, U.S. executive branch politics and administration\, emergency planning and preparedness\, and regulation of biotechnology. He is the author of Pandemics and Polarization: Implications of Partisan Budgeting for Responding to Public Health Emergencies (Lexington Books\, 2019). \nDue to the coronavirus pandemic\, this event will be held as a live webinar instead of an in-person talk. Blackboard Collaborate Ultra works best with Google Chrome and does not work with Internet Explorer. Participants will be able to use the “Raise Hand” function in Blackboard Collaborate to ask questions at the end of Dr. Myer’s prepared remarks. \nEveryone who registers for the webinar will receive a 30% discount on his book. \nThis webinar will be recorded and the video will be posted to the YouTube channels for The Pandora Report and the Schar School of Policy and Government . \nIf you have any questions\, please email: biodefense@gmu.edu
URL:https://globalbiodefense.com/event/policy-vs-pandemics-polarization-and-public-health-emergency-preparedness/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200326T130000
DTEND;TZID=America/New_York:20200326T143000
DTSTAMP:20200324T160955Z
CREATED:20200324T160607Z
LAST-MODIFIED:20200324T160955Z
UID:42206-1585227600-1585233000@globalbiodefense.com
SUMMARY:APIC AIHA Webinar - Ventilation\, Surface Disinfection and PPE Considerations for the IP and IH
DESCRIPTION:Amidst the flood of information about the COVID-19 pandemic\, one of the greatest risks is missing key intelligence that can protect health and save lives. This town hall-style webinar\, co-hosted by AIHA and the Association for Professionals in Infection Control and Epidemiology (APIC)\, will address occupational health and safety professionals’\, industrial hygienists’ and infection preventionists’ questions about ventilation\, surface disinfection\, respirators\, construction issues\, occupational health and safety during the COVID-19 pandemic.\nFull webinar description. \nAre you a 2020 Full eLearning Subscriber? This webinar is included in your subscription.\nIf you are purchasing this registration for another person\, please contact the eLearning staff at 1-703-849-8888. \nREGISTRATION INFORMATION\nEach person interested in attending needs their own registration. If you are unable to participate live\, you will have access to the recording for 90 days\, and you’ll be notified via email once the recording is available in the Online Classroom.When registering\, please only register once. Once you checkout\, the system will prompt you to sign in with your AIHA credentials\, or to create a new account. Once you complete either process\, you will checkout\, verify your information\, and confirm your order. \nDue to an increased volume of registrations\, please allow an hour to receive the confirmation message. You may need to check your junk folder.
URL:https://globalbiodefense.com/event/apic-aiha-webinar-ventilation-surface-disinfection-and-ppe-considerations-for-the-ip-and-ih/
LOCATION:Webinar
CATEGORIES:Conference,Training,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200408T140000
DTEND;TZID=America/New_York:20200408T153000
DTSTAMP:20200402T171318Z
CREATED:20200402T170907Z
LAST-MODIFIED:20200402T171318Z
UID:42524-1586354400-1586359800@globalbiodefense.com
SUMMARY:NASEM Webinar: The Supply Chain and COVID-19
DESCRIPTION:COVID-19 has had a profound impact on supply chains for many different critical products worldwide. The pandemic has created major changes in freight flows and has challenged the ability to deliver both medical supplies and food. \nThe National Academies’ Transportation Research Board (TRB) is hosting a webinar on Wednesday\, April 8\, 2020\, from 2:00 to 3:30 PM Eastern that will explore the impacts of COVID-19 on the supply chain and logistics industries. Presenters will discuss lessons learned from past freight transportation and supply chain disruptions\, identify research that has been done to address resilience in the supply chain\, describe how to mitigate the economic impacts of these disruptions\, and provide commentary on current supply chain disruptions due to COVID-19. The webinar is free to attend\, but registration is required. You can follow the conversation on Twitter by using #COVID19 and #TRBwebinar. \nWebinar Participants\n• Moderated by: Mike Meyer\, WSP\, Principal Investigator for NCFRP Research Report 39: Freight Transportation Resilience in Response to Supply Chain Disruptions\n• Paul Bingham\, IHS Markit\, expert in supply chain logistics\, freight transportation\, and transportation economics\n• Anne Strauss-Wieder\, North Jersey Transportation Planning Authority\, expert in supply chain and freight movement\, transportation policy\, and maritime transportation \nWebinar Outline \n1. How the supply chain industry has responded to past disruptions\n2. Lessons learned from past disruptions and best practices for a resilient supply chain\n3. How supply chain and logistics managers can respond to disruptions from COVID-19\n4. Question and answer session\nThe first 60 minutes of the webinar will be for presentations and the final 30 minutes will be reserved for audience questions. \nResources about supply chain and logistics from TRB: \n\nNCFRP Research Report 39: Freight Transportation Resilience in Response to Supply Chain Disruptions\nE-Circular E-C259: International Transportation and Economic Development Conference 2018\nTR News article: Supply Chain Business Continuity\nTR News article: Aviation’s Evolving Role in a Changing Climate\nTRB Director Neil Pedersen’s message regarding COVID-19
URL:https://globalbiodefense.com/event/nasem-webinar-the-supply-chain-and-covid-19/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200415T123000
DTEND;TZID=America/Los_Angeles:20200415T140000
DTSTAMP:20240623T231227Z
CREATED:20200408T174031Z
LAST-MODIFIED:20240623T231227Z
UID:42787-1586953800-1586959200@globalbiodefense.com
SUMMARY:Protecting Older Adults from the Harms of Social Isolation and Providing a Continuum of Care During COVID-19
DESCRIPTION:Join Trust for America’s Health (TFAH) on Wednesday\, April 15th for the webinar Protecting Against the Harms of Social Isolation During COVID-19. \nThe ongoing COVID-19 crisis presents unique challenges for the public health and aging sectors. While social distancing protects older adults who are at higher risk for complications from the virus\, the practice can exacerbate social isolation\, a longstanding issue for this population. \nAttendees will learn about the consequences of social isolation\, how the aging services sector has adapted its delivery models\, promising practices from the field and the importance of working with public health partners to address the needs of older adults.
URL:https://globalbiodefense.com/event/protecting-older-adults-from-the-harms-of-social-isolation-and-providing-a-continuum-of-care-during-covid-19/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200415T170000
DTEND;TZID=America/New_York:20200415T183000
DTSTAMP:20240623T192248Z
CREATED:20200414T182247Z
LAST-MODIFIED:20240623T192248Z
UID:43055-1586970000-1586975400@globalbiodefense.com
SUMMARY:APHA and National Academy of Medicine Webinar: Crisis Standards of Care During COVID-19
DESCRIPTION:Brought to you by the American Public Health Association and the National Academy of Medicine\, this webinar series is exploring the state of the science surrounding the current outbreak of COVID-19 in the United States and globally\, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health\, infectious disease\, risk communication\, and crisis standards of care. \nWebinar #4: Crisis Standards of Care During COVID-19\nWednesday\, April 15\, 5-6:30 p.m. ET \nThe fourth COVID-19 Conversations webinar will provide an overview of crisis standards of care during a pandemic\, challenges for adapting such standards to rapidly evolving clinical care guidelines\, practical considerations for state health departments and hospital systems\, and ethical considerations for decision-making while enacting crisis standards of care. \nThe expert panel for this webinar includes: \n\nJohn L. Hick\, MD\, is a faculty emergency physician at Hennepin County Medical Center and an Associate Professor of Emergency Medicine at the University of Minnesota Medical School. He serves as the Associate Medical Director for Hennepin County Medical Services and Medical Director for Emergency Preparedness at HCMC. He is medical advisor to the Minneapolis/St. Paul Metropolitan Medical Response System. He also serves the Minnesota Department of Health as the Medical Director for the Office of Emergency Preparedness and Medical Director for Hospital Bioterrorism Preparedness. He is the founder and past chair of the Minneapolis/St. Paul Metropolitan Health Compact\, a 29-hospital mutual aid and planning group. The regional program was recognized with a $2.5 million competitive HHS preparedness grant in 2007. Hick traveled to Greece as part of a 15-member CDC/HHS team to assist with health care system preparations for the 2004 Summer Olympics. He continues to work with HHS and other agencies on issues of hospital surge capacity planning\, adjusted standards of care in disasters\, and preparedness for nuclear terrorism.\n\n  \n\nRebecca E. Gee\, MD\, is the Secretary of the Louisiana Department of Health\, the state’s largest agency with a budget of $14 billion\, and Gratis Assistant Professor at the LSU Schools of Public Health and Medicine. Her oversight responsibilities include public health and other direct service programs for citizens in needs such as behavioral health\, developmental disabilities\, aging and adult services\, emergency preparedness ad the Medicaid program. Her Medicaid expansion work resulted in an additiona 500\,000+ Louisiana residents being newly insured and the launch of a dashboard to measure access to health care services that has become a national model used in other states. She is an OB/GYN\, trained policy expert and previously served as the director of the Birth Outcomes Initiative\, where she led the charge to decrease infant mortality and prematurity statewide — an effort that in part led to a 25% reduction in infant mortality\, an 85% drop in elective deliveries before 39 weeks and a 10% drop in NICU admissions.\n\n  \n\nJeffrey Kahn\, PhD\, MD\, is the is the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics and the inaugural Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy. He is also Professor in the Department of Health Policy and Management of the Johns Hopkins Bloomberg School of Public Health. He works in a variety of areas of bioethics\, exploring the intersection of ethics and health/science policy. Kahn has served on numerous state and federal advisory panels and is currently chair of National Academies of Sciences\, Engineering\, and Medicine’s Board on Health Sciences Policy\, and has previously chaired its committee on the Use of Chimpanzees in Biomedical and Behavioral Research; the committee on Ethics Principles and Guidelines for Health Standards for Long Duration and Exploration Spaceflights; and a committee on the Ethical\, Social\, and Policy Considerations of Mitochondrial Replacement Techniques. He also formerly served as a member of the National Institutes of Health Recombinant DNA Advisory Committee. In addition to committee leadership and membership\, he is an elected member of the National Academy of Medicine and an elected Fellow of The Hastings Center. He was also the founding president of the Association of Bioethics Program Directors. He is a co-principal investigator with Berman Institute faculty member Gail Geller\, ScD\, MHS\, on GUIDE: Genomic Uses in Infectious Disease and Epidemics\, an NIH-funded project to study the largely unexplored ethical\, legal and social implications of genomics as applied to infectious disease.\n\n  \n\nLawrence “Larry” O. Gostin\, JD\, directs the O’Neill Institute for National and Global Health Law and is the founding O’Neil Chair in Global Health Law at Georgetown University. He served as associate dean for research at Georgetown Law from 2004-2008 and is professor of medicine at Georgetown University and professor of public health at Johns Hopkins University. He is director of the World Health Organization Collaborating Center on National and Global Health Law. Among his appointed posts at WHO\, he served on the Director-General’s Advisory Committee on Reforming the World Health Organization\, is on the International Health Regulations Roster of Experts and has served on many WHO expert advisory committees including on the Pandemic Influenza Preparedness Framework and on the WHO/Global Fund Blue Ribbon Expert Panel: The Equitable Access Initiative to develop a global health equity framework. He co-chairs the Lancet Commission on Global Health Law. He served on two global commissions to report on the lessons learned from the 2015 West African Ebola epidemic and was senior advisor to the United Nations Secretary General’s post-Ebola Commission. Gostin also served on the drafting team for the G-17 Summit in Tokyo in 2016\, focusing on global health security and universal health coverage.
URL:https://globalbiodefense.com/event/apha-and-national-academy-of-medicine-webinar-crisis-standards-of-care-during-covid-19/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200421T130000
DTEND;TZID=Europe/London:20200421T140000
DTSTAMP:20240623T192624Z
CREATED:20200406T161624Z
LAST-MODIFIED:20240623T192624Z
UID:42642-1587474000-1587477600@globalbiodefense.com
SUMMARY:DASA Biosensing Across Wide Areas Phase 2 Launch
DESCRIPTION:Join the Defence and Security Accelerator for a dial-in on 21 April 2020\, 1pm to 2pm. The competition team will provide a short briefing on the Biosensing Across Wide Areas Phase 2 competition followed by an open forum Q&A session. \nOne to Ones\nThere will be two opportunities for One to One dial-in sessions with the competition team: \n\nWednesday 21 April 2020 –  2.30pm to 4pm: Three slots available\nThursday 22 April 2020 – 1pm to 3pm: Four slots available\n\nThese pre-bookable 20 minute one to one slots will be with the competition team to discuss questions specific to your proposal. Slots are on a first come\, first serve basis. \nPlease note: \n\na separate link will be sent to you on your ticket confirmation to register for a one to one slot\ndetails of the dial in will be sent before the meeting commences\nif the event is oversubscribed\, we may place a limitation on the number of attendees from a single organisation\n\n// \nREAD MORE: UK Launches Wide-Area Biosensor Competition
URL:https://globalbiodefense.com/event/dasa-biosensing-across-wide-areas-phase-2-launch/
CATEGORIES:Conference,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/04/97aef6bbedcf01db65e877ee6755e43d.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200520T110000
DTEND;TZID=America/Los_Angeles:20200520T123000
DTSTAMP:20200513T135220Z
CREATED:20200513T135220Z
LAST-MODIFIED:20200513T135220Z
UID:45402-1589972400-1589977800@globalbiodefense.com
SUMMARY:COVID-19 and the Impact on Communities of Color: Our Nation’s Inequities Exposed
DESCRIPTION:The webinar will highlight the disproportionate health and economic impacts the pandemic is having on communities of color and the short- and long-term efforts needed to advance equity in the response to and recovery from the COVID-19 pandemic and future public health emergencies. There will also be a focus on recent federal legislation and state actions in response to COVID-19.
URL:https://globalbiodefense.com/event/covid-19-and-the-impact-on-communities-of-color-our-nations-inequities-exposed/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200604T140000
DTEND;TZID=America/Los_Angeles:20200604T160000
DTSTAMP:20200605T214039Z
CREATED:20200527T213856Z
LAST-MODIFIED:20200605T214039Z
UID:46255-1591279200-1591286400@globalbiodefense.com
SUMMARY:COVID-19 Testing and Testing Related Activities with CDC Experts
DESCRIPTION:On Thursday June 4th at 2:00 pm\, the National Association of Rural Health Clinics will be hosting a webinar with experts from the CDC who will be talking about COVID-19 testing and testing related activities. \n\nExperts will talk about the actual testing process\, best practices for collecting samples\, how to align with state officials for more state-specific information and much more. There will also be ample time built into the session for questions from the audience. This webinar is free and open to all. Please feel free to share this information with others whom you think might benefit from participating in this webinar.
URL:https://globalbiodefense.com/event/covid-19-testing-and-testing-related-activities-with-cdc-experts/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200609
DTEND;VALUE=DATE:20200611
DTSTAMP:20200609T170801Z
CREATED:20200527T162939Z
LAST-MODIFIED:20200609T170801Z
UID:46303-1591660800-1591833599@globalbiodefense.com
SUMMARY:APG Advance Planning Briefing to Industry 2020
DESCRIPTION:The Aberdeen Proving Ground (APG) Advance Planning Briefing to Industry (APBI) and Technological Expo\, will be held virtually on 9-10 June 2020\, in lieu of being hosted live at APG\, MD. \nThe goal of the APG APBI is to provide industry with networking opportunities for both large and small businesses. The APBI will describe potential future contracting opportunities for mission areas that focus on: \n\nChemical and Biological Defense\nCommand\, Control\, Communications\, Computers\, Cyber\, Intelligence\, Surveillance\, and Reconnaissance\nResearch and Development\nTest and Evaluation\nAPG Garrison\n\nThe APG APBI will identify potential contracting opportunities that are aligned with the roadmaps of each respective organization\, specifically focusing on Fiscal Years 2021–2022. The Government will not hear formal bids from industry\, as the purpose of the APBI is for the Government to brief upcoming opportunities to industry to help it better understand Army capability requirements and shape its internal development efforts. \nDAY ONE \n0730–0830 Microsoft Teams Setup\n0830–0845 Welcome Remarks by MG Kilgo\n0850–0950 Army Contracting Command-Aberdeen Proving Ground\n0955–1125 Army Contracting Command-Aberdeen Proving Ground: Role of Division Chiefs\n1130–1245 Communications-Electronics Command Defense Logistics Agency-Aberdeen Proving Ground\n1330–1445 Program Executive Office Command Control Communications-Tactical & Network Cross-Functional Team\n1450–1520 Joint Program Executive Office for Chemical\, Biological\, Radiological and Nuclear Defense  Click to download slides for JPEO-CBRND presentation \nDAY TWO \n0730–0830 Microsoft Teams Setup\n0830–0930 Program Executive Office for Intelligence\, Electronic Warfare & Sensors\n0935–1005 Program Executive Office for Intelligence\, Electronic Warfare & Sensors: C5 OTA Consortium Overview\n1010–1040 Program Executive Office for Intelligence\, Electronic Warfare & Sensors: Multi-Domain Sensing System Contract Strategy Overview\n1045–1115 Program Executive Office for Intelligence\, Electronic Warfare & Sensors: PM\, Electronic Warfare & Cyber 21 Strategic Planning Guidance\n1120–1150 Combat Capabilities Development Command\n1155–1225 Combat Capabilities Development Command-CMOSS\n1230–1300 Army Test and Evaulation Command\n1305–1335 A Message from the Office of Small Business Programs\n1340–1410 APG Garrison\n1415–1445 Closing Remarks by MG Kilgo \nThe APG APBI will be unclassified and open to all interested contractors\, large and small businesses\, and academia\, as well as other Government stakeholders. There is no registration required for this event. \nIf you or your company has already purchased a ticket for APBI or reserved a table for the 2020 Team APG Tech Expo\, please contact MissionTix directly for a refund. MissionTix contact information is: 888-996-4774 or help@missiontix.com.
URL:https://globalbiodefense.com/event/apg-advance-planning-briefing-to-industry-2020/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Government Hosted,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/06/apg-abpi-cbrne-2020.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200616T100000
DTEND;TZID=America/New_York:20200616T120000
DTSTAMP:20200709T194433Z
CREATED:20200609T193108Z
LAST-MODIFIED:20200709T194433Z
UID:46622-1592301600-1592308800@globalbiodefense.com
SUMMARY:COVID-19 Effects on the Food and Agricultural System
DESCRIPTION:The Board on Agriculture and Natural Resources (BANR) of the National Academies of Science\, Engineering\, and Medicine hosted a webinar on Friday\, June 19 from 10:00 – Noon EDT with a virtual panel discussion on COVID 19 effects on the food and agricultural system\, which has experienced severe stress from a combination of factors. Workers’ health has been placed at risk\, producers have lost markets\, and animals and crops have been sacrificed. Meanwhile\, food prices are on the rise and unemployed Americans have turned in greater numbers than ever to overstressed food banks. A panel of distinguished participants in the food and agricultural system offered perspectives on the impacts and how we can learn from them. \nInvited perspectives include: \n\nA.G. Kawamura\, Owner\, Orange County Produce\, and former Secretary of the California Department of Food and Agriculture (2003-2010)\nTom Vilsack\, President and CEO\, U.S. Dairy Export Council\, and former United States Secretary of Agriculture (2009 – 2017)\n\nThe session was moderated by BANR Chairman\, Chuck Rice (Kansas State University). Members of the Board on Agriculture and Natural Resources lead with questions to the presenters\, and the public was able to type in questions to be asked by the moderator. \nVisit NASEM’s website to register.
URL:https://globalbiodefense.com/event/covid-19-effects-on-the-food-and-agricultural-system/
CATEGORIES:Conference,Webinar-Webcast,Workshop
LOCATION:https://vimeo.com/430827259
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200617
DTEND;VALUE=DATE:20200618
DTSTAMP:20200520T204211Z
CREATED:20200520T204211Z
LAST-MODIFIED:20200520T204211Z
UID:45697-1592352000-1592438399@globalbiodefense.com
SUMMARY:Biotechnology for Materiel and Defense Symposium
DESCRIPTION:The Biotechnology for Material and Defense Symposium virtual event will be hosted by the National Defense Industrial Association on June 17\, 2020. \nRecent advances in Synthetic Biology\, Biotechnology\, and their supporting infrastructure—biodesign\, automation\, artificial intelligence\, and data analytics—are affording transformational impacts beyond traditional opportunity spaces to produce natural polymers and composites\, synthesize new molecules for coatings and resins\, and ‘grow’ structural materials such as leathers and foams. \nFuture capabilities such as biosensors and nano-structure material production are on the cusp of implementation. The far future promises the ability for in-situ production\, self-healing\, and more. This ability to harness nature’s processes to produce molecules and materials in a sustainable way has the potential to not only have a positive impact on the environment and domestic manufacturing but also radically change how we design\, build\, maintain\, and support our troops. \nPlease visit the NDIA’s Biotechnology for Material and Defense Symposium website for more information and to register. \n 
URL:https://globalbiodefense.com/event/biotechnology-for-materiel-and-defense-symposium/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200629T133000
DTEND;TZID=America/New_York:20200629T143000
DTSTAMP:20200624T201831Z
CREATED:20200624T201628Z
LAST-MODIFIED:20200624T201831Z
UID:46424-1593437400-1593441000@globalbiodefense.com
SUMMARY:COVID-19\, Systemic Racism\, and the Responses of HBCUs: A Virtual Town Hall Discussion
DESCRIPTION:The National Academies of Sciences\, Engineering and Medicine Board on Higher Education and Workforce will host a virtual town hall on Jun 29\, 2020 to discuss COVID-19\, Systemic Racism\, and the Responses of HBCUs. \nHistorically Black Colleges and Universities (HBCUs) are among the nation’s most vital and vibrant institutions\, serving the educational needs of hundreds of thousands of students\, advancing the full spectrum of human knowledge\, and invigorating the cultural\, social\, and economic horizons of the regions they serve. And today\, these universities are at the forefront of the fight against COVID-19\, researching treatments\, keeping their states and communities informed\, and treating patients at academic medical centers.  They are also at the forefront of the nation’s struggles against institutionalized discrimination\, systemic inequality\, and anti-Black racism that are being brought to bear every day in the forms of demonstrations and advocacy in most U.S. communities. \nHow have HBCUs responded to the COVID-19 pandemic and to the recent events surrounding the murder of George Floyd?  As HBCU presidents look toward resuming in-person classes in the fall\, what have they learned from the COVID-19 crisis\, how will their institutions evolve as a result\, and what might that mean for the future of HBCUs in America?  How will HBCUs adapt to the serious financial challenges likely to arise in states and the nation in the months ahead as a consequence of COVID-19? What are HBCU campus leaders doing in preparation for a stronger and higher-profile role in terms of advocacy and leadership in directly addressing anti-Black racism in this country? \nPlease join the presidents of three of the nation’s premier HBCUs as they discuss COVID-19 and issues of racial injustice. This event is hosted by the National Academies’ Board on Higher Education and Workforce and Issues in Science and Technology and sponsored by the Kresge Foundation and the U.S. Department of Defense HBCU/MI Program. \nSpeakers include: \n\nMakola M. Abdullah\, President of Virginia State University\nMary Schmidt Campbell\, President of Spelman College\nC. Reynold Verret\, President of Xavier University of Louisiana\n\nModerated by Gilda Barabino\, President-elect of Olin College of Engineering \nPlease contact John Veras (jveras@nas.edu) for questions.
URL:https://globalbiodefense.com/event/covid-19-systemic-racism-and-the-responses-of-hbcus-a-virtual-town-hall-discussion/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/06/covid-19-systemic-racism-hbcu-black-colleges-nasem.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200702T110000
DTEND;TZID=America/New_York:20200702T123000
DTSTAMP:20200624T194613Z
CREATED:20200624T194613Z
LAST-MODIFIED:20200624T194613Z
UID:46421-1593687600-1593693000@globalbiodefense.com
SUMMARY:The U.S. Chemical Supply Chain: Vulnerabilities Highlighted by COVID-19
DESCRIPTION:The National Academies Board on Chemical Sciences and Technology will convene a webcast meeting on July 2\, 2020 to discuss The U.S. Chemical Supply Chain: Vulnerabilities Highlighted by COVID-19. \nThroughout the COVID-19 pandemic\, the chemical industry in the United States has maintained operating status and continues to be at the forefront of worker safety. Despite these achievements\, the pandemic exposed some of the vulnerabilities in the chemical industry’s supply chain. \nWith an increased demand for chemical products\, such as isopropyl alcohol for the production of hand sanitizer\, the United States has seen firsthand the inflexibility of the supply chain to increase or alter production. The “just-in-time” manufacturing approach that many companies previously adopted to maximize efficiency and lower costs has now presented the industry with production challenges and raises the question of how demand can be met if a disruption to the supply chain occurs. Also of note are the specialty chemical and pharmaceutical industries\, which are increasingly vulnerable as they have outsourced many of their operations overseas. \nIn the event of a global disruption or a localized disruption unique to the point of origin\, the United States risks not being able to obtain the products it critically needs—such as personal protective equipment\, medications\, and medical equipment—as has occurred in the case of COVID-19. \n This webinar\, hosted by the Chemical Sciences Roundtable\, will aim to highlight these two vulnerabilities in the supply chain: the inelasticity of the chemical supply chain and the risks posed by the overseas manufacturing of specialty and pharmaceutical chemicals. \nSpeakers include: \n\nDr. David Bem\, VP of Science and Technology and CTO at PPG Industries\, Inc.\nDr. T. Kevin Swift\, Chief Economist at American Chemistry Council\nDr. Ron Piervincenzi\, CEO of United States Pharmacopeia\n\nA recording of the webinar will be made available after the event. Click here to register for this event.
URL:https://globalbiodefense.com/event/the-u-s-chemical-supply-chain-vulnerabilities-highlighted-by-covid-19/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/06/chemical-sciences-roundtable-nasem-covid-19.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200721T100000
DTEND;TZID=America/New_York:20200721T150000
DTSTAMP:20200709T183244Z
CREATED:20200709T183155Z
LAST-MODIFIED:20200709T183244Z
UID:46618-1595325600-1595343600@globalbiodefense.com
SUMMARY:COVID Complexities: Converging Threats\, Fractured Resources
DESCRIPTION:A virtual meeting of the Bipartisan Commission on Biodefense will be held on July 21\, 2020 to discuss “COVID Complexities: Converging Threats\, Fractured Resources”. \nThe ongoing novel coronavirus 2019 (COVID-19) pandemic has taken the lives of more than 100\,000 Americans and damaged the Nation’s economy. As the country reopens\, the disease threatens the public\, now and into the foreseeable future. Federal support for state\, local\, tribal and territorial preparedness and biosurveillance will be crucial to addressing further spread of COVID-19. The Commission intends to address national policy and resource needs for response to and recovery from this crisis. \nSpeakers include: \nJared Moskowitz – Director\, Florida Division of Emergency Management \nAlexis Madrigal – Co-Founder\, The COVID Tracking Project\, and Staff Writer\, The Atlantic \nDavid Mitchell – President\, International Association of Emergency Medical Services Chiefs \nSpeakers will discuss the potential for compoundment of the biological threat\, disease-tracking needs\, hospital preparedness\, and emergency management challenges. \nPlease visit the Bipartisan Commission on Biodefense website to register for this free event.
URL:https://globalbiodefense.com/event/covid-complexities-converging-threats-fractured-resources/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://globalbiodefense.com/event/covid-complexities-converging-threats-fractured-resources/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200722T140000
DTEND;TZID=America/New_York:20200722T163000
DTSTAMP:20200709T212451Z
CREATED:20200709T212352Z
LAST-MODIFIED:20200709T212451Z
UID:46694-1595426400-1595435400@globalbiodefense.com
SUMMARY:Next Steps for Functional Genomics: A Workshop and Proceedings Release
DESCRIPTION:The National Academies of Sciences\, Engineering\, and Medicine (NASEM) will convene in a virtual meeting open to the public on July 22\, 2020 to unveil and summarize written proceedings a previous workshop on the future of functional genomics research. \nDuring this proceedings release\, you will have the opportunity to hear from Gene Robinson and Lauren O’Connell\, who were members of the workshop planning committee\, about important insights that were gained over the course of the workshop. \nThe workshop itself was held in February in Washington\, DC\, and included speakers\, panels\, and interactive sessions\, that explored the scientific advancements needed to utilize functional genomics to solve societal problems in areas such as conservation\, evolutionary studies\, agriculture\, energy\, defense\, human health\, and other sectors. \nOver the course of the workshop speakers and participants looked to address the current state of the science\, what lessons have been learned thus far\, what current impediments there are to further progress\, and areas where additional investments could help move the field forward. Importantly\, the workshop served as a platform for discussion within the functional genomics community. \nPlease visit the NASEM website to register. \n 
URL:https://globalbiodefense.com/event/next-steps-for-functional-genomics-a-workshop-and-proceedings-release/
CATEGORIES:Conference,Webinar-Webcast,Workshop
LOCATION:https://nasem.zoom.us/webinar/register/WN_HRB5dQrxRaq16gYVKyZnmA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200923T090000
DTEND;TZID=America/New_York:20200923T160000
DTSTAMP:20200922T212137Z
CREATED:20200822T211622Z
LAST-MODIFIED:20200922T212137Z
UID:47153-1600851600-1600876800@globalbiodefense.com
SUMMARY:Leveraging Data Science Approaches to Address Environmental Health Challenges in Africa
DESCRIPTION:Environmental Health challenges in Africa are complex\, involving a broad range of exposures\, including ambient and indoor air pollution\, electronic waste\, heavy metals\, pesticides\, vector-borne pathogens\, and climate change\, and a large proportion of the disease burden in Africa is linked to environmental factors. This session will explore unique aspects and analytic challenges of the various types of environmental health data and will highlight recent data science approaches to characterizing hazardous exposures on the African continent\, connecting environmental exposures to health outcomes\, and reducing the risk of disease connected to the environment. \nModerator:\nGwen Collman\, Acting Deputy Director\, Associate Director for Extramural Research\, National Institute of Environmental Health Sciences \nPanelists:\nKiros Berhane\, Professor and Chair\, Department of Biostatistics\, Mailman School of Public Health\, Columbia University \nCaradee Wright\, Senior Specialist Scientist\, Environment and Health Research Unit\, South African Medical Research Council \nEngineer Bainomugisha\, Associate Professor and Chair\, Department of Computer Science\, School of Computing & IT\, Makerere University \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/leveraging-data-science-approaches-to-address-environmental-health-challenges-in-africa/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200923T130000
DTEND;TZID=America/New_York:20200923T140000
DTSTAMP:20200920T191330Z
CREATED:20200920T191330Z
LAST-MODIFIED:20200920T191330Z
UID:47120-1600866000-1600869600@globalbiodefense.com
SUMMARY:The Effects of COVID-19 on Latin America and the Economic Outlook
DESCRIPTION:Please join the CSIS Americas Program and the CSIS Economics Program for a discussion on how the Covid-19 pandemic is affecting the outlook in Latin America. The ongoing surge in Covid-19 cases across the region raises questions about the timing of recovery\, adequacy of macroeconomic responses\, and the role of private and official sectors in responding to the unprecedented health and economic crises. This event will explore these issues\, as well as sector-specific outlooks in the wake of the pandemic\, and the outlook for sovereign and corporate debt. \nFeaturing a discussion with Geoffrey Okamoto\, Deputy First Managing Director\, International Monetary Fund. \nFollowed by a panel discussion: \n\nChris Campbell\, Chief Strategist\, Duff & Phelps Institute\nKevin Gallagher\, Professor of Global Development Policy\, Boston University\, and Director of the Global Development Policy Center\nSamar Maziad\, Vice President and Senior Analyst\, Sovereign\, Moody’s Investors Service\n\nModerated by Stephanie Segal\, Senior Fellow\, Economics Program\, CSIS \nThis event is made possible thanks to the generous support of the Duff & Phelps Institute. \nFEATURING\n\n\n\nGeoffrey Okamoto\nFirst Deputy Managing Director\, International Monetary Fund\n\n\n\n\n\nSamar Maziad\nVice President and Senior Analyst\, Sovereign\, Moody’s Investors Service\n\n\n\n\n\nKevin Gallagher\nProfessor of Global Development Policy\, Boston University\, and Director of the Global Development Policy Center\n\n\n\n\n\nChristopher Campbell\nChief Strategist\, Duff & Phelps Institute
URL:https://globalbiodefense.com/event/the-effects-of-covid-19-on-latin-america-and-the-economic-outlook/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200924T090000
DTEND;TZID=America/New_York:20200924T124500
DTSTAMP:20200922T011659Z
CREATED:20200922T010030Z
LAST-MODIFIED:20200922T011659Z
UID:47128-1600938000-1600951500@globalbiodefense.com
SUMMARY:The Biological Event Horizon: No Return or Total Resilience
DESCRIPTION:A virtual meeting of the Bipartisan Commission on Biodefense will be held on Sep. 24 entitled\, “The Biological Event Horizon: No Return or Total Resilience“. \nThe ongoing novel coronavirus 2019 (COVID-19) pandemic is revealing major gaps in national readiness to prepare for\, respond to\, and recover from biological threats. Decision makers must consider enhancements to policies and programs to better defend against the next biological threat as the Nation continues to respond to the crisis. COVID-19 will not be the last biological threat we face and it likely will not be the worst as the risk of natural and human-generated threats continues to increase with time. \nAt this meeting\, the Commission intends to address these emerging biological threats and innovative science and technology solutions to address them. \nSpeakers include: \n\nJaime Yassif\, PhD: Senior Fellow\, Global Biological Policy and Programs\, Nuclear Threat Initiative\nSohini Ramachandran\, PhD: Associate Professor of Biology\, Director of Graduate Studies for the Center for Computational Molecular Biology\, Associate Professor of Computer Science\, Brown University\nNita Madhav\, MSPH\, Chief Executive Officer\, President\, and Board Member\, Metabiota\nRepresentative Susan Brooks (R-IN):  Member\, Subcommittee on Health\, Committee on Energy and Commerce\, U.S. House of Representatives\nRepresentative Diana DeGette (D-CO): Chair\, Subcommittee on Oversight and Investigation\, Committee on Energy and Commerce\, U.S. House of Representatives\nKavita M. Berger\, PhD: Director\, Board on Life Sciences\, National Academies of Sciences\nLuciana Borio\, MD: Vice President\, Technical Staff\, In-Q-Tel; Former Director for Medical and Biodefense Preparedness\, National Security Council; Former Assistant Commissioner for Counterterrorism Policy and Director\, Office of Counterterrorism and Emerging Threats\, Office of the Chief Scientist\, FDA; and Former Senior Medical Advisor\, Office of the ASPR\, DHHS\n\nPlease visit the Bipartisan Commission on Biodefense website for more information. \nGlobal Biodefense is not affiliated with the Bipartisan Commission on Biodefense and is providing this listing as a courtesy to the community.
URL:https://globalbiodefense.com/event/the-biological-event-horizon-no-return-or-total-resilience/
CATEGORIES:Policy-Legislative,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200924T130000
DTEND;TZID=America/New_York:20200924T143000
DTSTAMP:20200922T011528Z
CREATED:20200919T010636Z
LAST-MODIFIED:20200922T011528Z
UID:47130-1600952400-1600957800@globalbiodefense.com
SUMMARY:Clearing the Path: Responding to Disasters During a Crisis
DESCRIPTION:The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) is convening a diverse group of public-private partners to present\, Clearing the Path: Responding to Disasters During a Crisis\, a virtual discussion for National Preparedness Month\, on September 24\, 2020\, from 1:00 p.m. – 2:30 p.m. EST. \nWhen responding to natural disasters during a crisis\, such as the COVID-19 pandemic\, emergency responders\, hospitals\, and supply chains are working at capacity\, while the next hurricane\, wildfire\, or flood could be around the corner. For communities to adapt and respond to these compounding pressures\, they must understand how technologies can inform risk-based decision making in areas of neighborhood health monitoring\, supply chains\, evacuation planning\, crisis communications\, and information sharing among front-line responders. Innovation in predictive analytics\, modeling and simulation\, and mobility offer new solutions to tackle immediate challenges and prepare for emerging threats. \nTopics of this virtual discussion will include: \n\nUnderstanding how public-private partnerships are accelerating new solutions and business models to prepare for day-to-day emergencies and a national crisis.\nEducating community leaders on how new science and technology applications are enhancing resilience and protecting life-line systems and networks.\nWith increased frequency of new threats\, examining what new tools and policies are available to incentivize collaboration among government\, industry\, and foundations.\nWith communities investing in automated and digital technologies\, asking why this is important and how predictive data sets are changing the way we think about risk and preparedness.\n\nSpeakers include: \n\nDavid Maurstad\, Deputy Associate Administrator\, FEMA\n\n\nDuane Caneva\, Chief Medical Officer\, DHS Countering WMD Office\n\n\nTed Smith\, Ph.D.\, Wastewater Based Epidemiology\, Professor of Environmental Medicine\, University of Louisville and Advisor to Louisville Mayor\, Greg Fischer\n\n\nCatherine Cross\, Deputy Under Secretary\, DHS Science and Technology Directorate (S&T)\n\n\nDavid Corman\, Program Director\, Cyber-Physical Systems and Smart and Connected Communities\, National Science Foundation\n\n\nRichard Seline\, Executive Director\, Accelerate H2O\, Houston\, TX\n\n\nMichel Leonard\, Vice President and Senior Economist\, Insurance Information Institute\n\n\nModerator: David Alexander\, Director of Resilience Research and Partnerships\, DHS S&T\n\nTo register for the National Preparedness Month Virtual Discussion: Clearing the Path: Responding to Disasters During a Crisis\, please register here.
URL:https://globalbiodefense.com/event/clearing-the-path-responding-to-disasters-during-a-crisis/
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/national-preparedness-clearing-path-disaster-crisis-response-dhs.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200929T090000
DTEND;TZID=America/New_York:20200929T163000
DTSTAMP:20200922T180748Z
CREATED:20200922T180416Z
LAST-MODIFIED:20200922T180748Z
UID:47143-1601370000-1601397000@globalbiodefense.com
SUMMARY:Pediatric Countermeasures: Children's National - NIAID Partnership Virtual Symposium
DESCRIPTION:A virtual symposium highlighting pediatric COVID-19 and MIS-C pandemic efforts undertaken by the NIAID-Children’s Hospital partnership will take place virtually on 29 September\, 2020. \nThis one day symposium bringing together investigators\, researchers\, and clinicians from the National Institute of Allergy and Infectious Diseases (NIAID) and Children’s National Hospital as well as other interested participants from outside institutions\, to discuss the creation\, progress\, and evolution of this first-of-its-kind collaboration between the NIAID at the National Institutes of Health and Children’s National\, a pediatric academic medical center. \nThis year\, the event will highlight the current COVID-19 and MIS-C pandemic\, with a specific focus on the pediatric population. \nHighlighted speakers and topics include: \n\nOverview of SARS-CoV-2: Anthony S. Fauci\, MD (NIAID)\nRole of NCATS in the the SARS-CoV-2 Response: Christopher P. Austin\, MD (NCATS)\nHumoral Immune Response: Jeffrey I. Cohen\, MD (NIAID)\nCellular Response (T and NK Cells): Michael Keller\, MD (Children’s National)\nImmunopathogenesis of MIS-C: Sarah E. Henrickson\, MD\, PhD (CHOP)\nGenomic Factors in SARS-CoV-2: Helen Su\, MD\, PhD (NIAID)\nHealth Disparities and SARS-CoV-2: Akilah Jefferson Shah\, MD\, MSc (UAMS)\nClinical Spectrum of SARS-CoV-2\, Implication for Schools Reopening: Dan M. Cooper\, M.D. (UC Irvine)\nMIS-C and Post SARS-CoV-2 Monitoring in Children: Roberta DeBiasi\, MD\, MS (Children’s National)\nPost SARS-CoV-2 Monitoring in Adults: Michael C. Sneller\, MD (NIAID)\nOverview of Vaccine Candidates: Peter Hotez\, MD\, PhD (Baylor)\nCurrent State of Vaccine Clinical Trials: Julie Ledgerwood\, DO (NIAID)\nOngoing Therapeutic Trials and Treatment Guidelines: Cliff Lane\, M.D. (NIAID)\nSARS-CoV-2 What Comes Next – Societal/Economic Impact: Ezekiel Emanuel\, MD\, PhD (UPenn)\n\nIn 2017\, The National Institute of Allergy and Infectious Diseases (NIAID) and Children’s National Hospital launched a clinical research partnership devoted to protecting and advancing the health of children with allergic\, immunologic\, auto-inflammatory\, and infectious disease through collaborative research and education. This strategic and novel alliance is supported through the Clinical and Translational Science Institute at Children’s National (CTSI-CN). The partnership\, co-led by H. Clifford Lane\, M.D.\, Deputy Director for Clinical Research and Special Projects at NIAID\, and Mark Batshaw\, M.D.\, Executive Vice President and Chief Academic Officer at Children’s National\, holds the mission to generate and apply knowledge to promote the prevention\, diagnosis\, treatment\, and cure of these childhood diseases through its work together. \nFor each area\, designated investigators from each institution are collaborating to design and conduct clinical research studies that will advance prevention strategies\, diagnoses\, treatments\, and cures for the diverse range of pediatric diseases involving the immune system. Many of these studies will include children at high risk for complications related to their underlying disease or to experimental therapeutics and diagnostic tests they receive. Research participants will have the opportunity to be seen at both Children’s National and the NIH Clinical Center in Bethesda\, Maryland. Together\, the two institutions provide comprehensive\, state-of-the-art pediatric clinical support\, infrastructure\, and research capacity. These resources protect the safety of children\, ensure that they receive the highest quality of care\, and offer them the opportunity to participate in cutting-edge clinical research. In addition\, the partnership established joint training opportunities for physician-scientists interested in caring for these children while developing their research expertise in pediatric immunology\, allergic\, and infectious diseases. \nThe collaboration is supported through an NIAID supplement to the Clinical and Translational Science Institute at Children’s National\, which is funded by a Clinical and Translational Science Award from NIH’s National Center for Advancing Translational Sciences to Children’s National Hospital and The George Washington University. \nRegister here. \n 
URL:https://globalbiodefense.com/event/pediatric-countermeasures-childrens-national-niaid-partnership-virtual-symposium/
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/niaid-childrens-national-covid-19-research-countermeasures.jpg
LOCATION:
END:VEVENT
END:VCALENDAR